Public health research in Europe Mark McCarthy (University College London) Levels of health sciences molecules cells organs people populations Laboratory.

Slides:



Advertisements
Similar presentations
Mental health strategy of the Medical Research Council (UK) Opportunities for European engagement and a role of FEAM European Parliament 22 nd March 2011.
Advertisements

Implementing NICE guidance
Donald T. Simeon Caribbean Health Research Council
Meaningful Patient Involvement In FP7 Research Nicola Bedlington Meaningful Patient Involvement In FP7 Research Nicola Bedlington Open Information Day.
Norwegian support to health research on poverty related health problems – current situation and future plans Professor Roy H. Gabrielsen, Executive Director.
DFID review of impact of research on development – an MRC perspective
BOND Value for Money Discussions Feb 3 rd, Oxfam GB Oxfam International – confederation of 14 independent affiliate organisations, working in over.
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
Unit 12 Public Health Learning Outcomes:
VIII Evaluation Conference ‘Methodological Developments and Challenges in UK Policy Evaluation’ Daniel Fujiwara Senior Economist Cabinet Office & London.
Implementation of health research funding under H2020 SC 1- “Health, demographic change and wellbeing “ Elmar Nimmesgern PhD DG Research and Innovation.
Health Education and health promotion in Norwegian national curriculum Health Promotion is part of Section 9a in the Education Act, –“All pupils in primary.
HAS 3150 Chapter 10. Infectious Diseases Diseases caused by living microorganisms.
Clinical Lead Self Care and Prevention
Strategy Maps for Structuring Program Operating Plans: Family Planning Examples Public Health Foundation Paul Epstein, Results That Matter Team Kentucky.
Purposes and uses of cancer registration E.E.U. Akang Department of Pathology University College Hospital Ibadan, Nigeria.
An Introduction to Operations Research and Implementation Science or How can I make my (all) health programs better? Mark Micek, MD, MPH.
Rare Diseases Working Group Luzern, 24 September 2010.
Keith J. Mueller, Ph.D. Director, RUPRI Center for Rural Health Policy Analysis Head, Department of Health Management and Policy College of Public Health.
SPHERE: EPHA Extraordinary General Assembly SPHERE Strengthening Public Health Research in Europe Science Europe Health Gabrielle Harvey Mark.
LINKING SCIENCE and POLICY R E S E A R C H P R O M O T I O N F O U N D A T I O N OCT , 2009 AMATHUS HOTEL LIMASSOL International Workshop L eonidas.
REGIONAL REPRESENTATION IN BRUSSELS Securing effective working on the European Agenda Jeremy Howell Economic Development and European Policy Consultant.
Outcomes of Public Health
The involvement of patients in Health Technology Assessment Andrzej Rys Director Health and Consumers Directorate-General Brussels 18 May 2010.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
Second Annual UK Knowledge Mobilisation Forum April 2015 Royal College of Physicians of Edinburgh.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 The Sixth Framework Programme and Policy Support Research – “Priority 8” Parallel.
Evaluating the Effectiveness of the CTRC: Designing Quantitative and Qualitative Measures to Assess in Real Time the Value of the Center Mike Conlon, University.
Conducting Research in the UK National Health Service Dr Stephen Brett Reader In Critical Care.
Joost de Laat (Phd) Senior Economist Human Development Europe and Central Asia The World Bank.
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
Understanding real research 2.
Nursing Research Capacity Building. Background CON –opened as 9 th College at SQU in 2008 The CON’s next challenge is promoting nursing care based on.
Penny Emerit Acting Director of London Programmes May 2010 Polysystems: how do they support tackling health inequalities in Sectors and PCTs?
Implementation and process evaluation: developing our approach Ann Lendrum University of Manchester Neil Humphrey University of Manchester Gemma Moss Institute.
1 Environment and health information Content Scott Brackett.
A translational routemap for public health research Peter Craig Programme Manager, MRC PHSRN Knowledge Transfer Scotland, Heriot Watt University, 23 April.
Strategic Clinical Networks Update October 2012 Drafted by Denise Mclellan.
Prostate Cancer Research in Europe European Union Prostate Cancer Research Framework Program (FP) 6 FP6 funded projects in fiscal years 2004/2005 Total.
The Importance of Research in Tobacco Control Jeffrey Koplan, MD, MPH Emory Global Health Institute- China Tobacco Control Partnership.
Copyright © 2009 Elsevier Canada, a division of Reed Elsevier Canada, Ltd. The Role of Research in Nursing Chapter 1.
EU cooperation on HTA – the way forward Andrzej Rys Director European Commission DG Health and Consumers Health Systems and Products HTA 2.0 Europe - Teaming.
Innovating out of the recession in the NHS Steve Barnett, Chief Executive NHS Confederation 28 th October 2009 Foundation Trust Network - Primary Care.
NIHR Research Design Service London Enabling Better Research Dr Caroline Burgess General Adviser 13 th November 2013.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Community wide interventions for physical activity Clinical
Transparency and access to medical research Dr. Wim Weber European editor, BMJ.
SPHERE: Gastein Health Forum Research for the Citizens of Europe Science Europe Health Mark McCarthy Professor of Public Health University College London.
Careers in Public Health A Passion for Health. Are you passionate about health? Do you have drive and vision to improve people’s lives? Are you a strategic.
Working with Districts Helen Buckingham Andrew Scott-Clark.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Better health, better value How the NHS is changing Anne Swan Chief Executive NHS Bournemouth and Poole.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Implementation Science: Finding Common Ground and Perspectives Laura Reichenbach, Evidence Project, Population Council International Conference on Family.
1 RESEARCH INFRASTRUCTURES RESEARCH INFRASTRUCTURES in FP7 CARE Collaboration Meeting CERN, Switzerland, November 2005 Presentation by Daniel Pasini,
6th Framework Programme – Research for Policy - November 2002 The Sixth Framework Programme and Policy Support Research – “Priority 8” “Priority 8” - 6th.
Introduction Social ecological approach to behavior change
Centers for Disease Control & Prevention: Policy & Environmental Change Efforts Board of Human Sciences February 24, 2010 Laura Kettel Khan, PhD Sr Scientist.
Tackling Inequalities in Screening
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.
Amy L. Ai, PhD College of Social Work (Pepper Institute Associate; Psychology, Nursing, and Behavioral Science Adjuncts)
Philip Garner Health Improvement Principal
Putting Public Health Evidence in Action
Programme Analysis Planning, Monitoring, and Evaluating Programmes
WFPHA Global cCharter.
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Community Health Improvement Matrix
Presentation transcript:

Public health research in Europe Mark McCarthy (University College London) Levels of health sciences molecules cells organs people populations Laboratory Clinical - individual Public health

Health research spend in UK % of total health budget private & public research spend 7% public research 2.5% HSR research 0.3%

Research for policy support (‘translational research’) Good primary research Secondary databases ‘Tertiary products’ Implementation research

Public health research … The scientific study of improving the health of the population broad determinants, health promotion and health services not usually randomised controlled trials intervention more than aetiology

Is this science? basic (‘curiosity-driven’) and strategic (‘agenda-driven’) research both deliver practical benefits not ‘art of the possible’ (Medawar) but ‘science of the difficult’

DG Health: first programme Issues disease-based, not linked to outcomes selection not transparent not linked to other DGs

FP5 public health: retrospect Issues disease rather than ‘system’ focus rarely using European variation population studies observational rather than evaluative

FP6: how will it be for you? Issues thematic research (big money) gone to basic research (except cancer) policy research (small money) spread among several DGs - health focus limited Little engagement on public health from national governments / European Science Foundation

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.